- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07518472
Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease is progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.
Pulmonary rehabilitation along with different technqiues of breathing exercises reduces dyspnea and enhance functional capacity by improving ventilatory efficiency, respiratory muscle control and overall exercise tolerance in patients with COPD.
Study Overview
Status
Intervention / Treatment
Detailed Description
Chronic Obstructive pulmonary Disease is a progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.
Pulmonary Rehabilitation, a cornerstone in COPD management helps to reduce dyspnea and improve functional capacity. Although long-term PR programs yield sustained benefits, shorter-duration PR (e.g., 3-week interventions) may offer greater feasibility and higher patient adherence.
Total 40 participants will be allocated into two groups. Group A will be provided with short term Pulmonary rehabilitation along with pharmacological management and group B will be given additional Box breathing along with short term pulmonary rehabilitation The objective of this study is to determine the additional effects of Box breathing technique with short term pulmonary rehabilitation versus short term pulmonary rehabilitation alone on Dyspnea, Functional capacity and quality of life in patients with chronic obstructive pulmonary disease.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fanila Tamdeen, MSPT-CPT
- Phone Number: +923185085604
- Email: fanilatamdeen69@gmail.com
Study Contact Backup
- Name: Zara Khalid, PhD
- Phone Number: +92333-5415822
- Email: zara.khalid@fui.edu.pk
Study Locations
-
-
-
Islamabad, Pakistan
- Recruiting
- Foundation University Islamabad
-
Contact:
- Zara Khalid, PhD
- Phone Number: +92333-5415822
- Email: zara.khalid@fui.edu.pk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 40-65 years
- Both genders (male and female)
- Grade 1-3 on mMRC scale of dyspnea
- COPD mild stage according to global initiative for chronic obstructive lung -disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Exclusion Criteria:
- Patients having acute exerbation of COPD
- Patients diagnosed with acute infection (pmeumonia, T.B)
- Any orthopedic or neuromuscular condition that hinders participation in exercise training program
- Patients unable to follow command and instructions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Short term pulmonary rehabilitation
Patients in this group will receive Short term pulmonary rehabilitation along with pharmacological management. Two sessions per week, supervised by physiotherapist will be conducted for a total of 3 weeks. |
Patients in this group will receive short term pulmonary rehabilitation along with pharmacological management. A total of 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist. Short term pulmonary rehabilitation includes: Warm-up(5-7min): light walking Aerobic training: mild-moderate intensity (40-60% of MHR) cycling or walk on treadmill/over ground Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM. Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: Seated abdominal contraction, back extension Perform 1-2 sets of 5-10 repetitions for each exercise, resting 1-2 mins between sets. Breathing exercise: pursed-lip breathing (1-3 sets of 5-10 reps) Cool down: (5-10min) Pharmacological management: Patient will receive medications as per prescribed by pulmonologist |
|
Experimental: Box breathing with short term pulmonary rehabilitation
Patients in this group will receive Box breathing as well as short term pulmonary rehabilitation along with pharmacological management. Two sessions per weeek, supervised by physiotherapist will be conducted for a total of 3 weeks. In Group B, box breathing will be performed daily. A home diary will be provided in order to ensure and follow-up that the participants are performing breathing exercise at home. |
Patients in this group will receive box breathing with short term pulmonary rehabilitation along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and box breathing will be performed daily. Patient will receive short term pulmonary rehabilitation including: Warm -up (5-7 min): light walking Aerobic training: mild-moderate intensity (40-60%of MHR) cycling or walk on treadmill/over ground. Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM. Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: seated abdominal contractions, back extensions Perform 1-2 sets of 5-10 repetitions for each exercise resting 1-2 min between sets. Breathing exercise: pursed-lip breathing (1-3 sets of 5 -10 repetitions) Cool down: (5-10 min) Box breathing: The patient will be instructed |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyspnea
Time Frame: 03 weeks
|
Evaluation will be performed using the Modified Medical Research Council (mMRC) Dyspnea Scale, a clinician-administered scale ranging from 0 to 4, where: 0 indicates breathlessness only with strenuous exercise 4 indicates severe breathlessness (too breathless to leave the house or breathless while dressing) Higher scores represent worse dyspnea severity and poorer functional status. |
03 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Capacity
Time Frame: 03 weeks
|
Evaluation will be done by using 6 minute walk test
|
03 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FUCP/CTR/2026/01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive (COPD)
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
-
Elpen Pharmaceutical Co. Inc.Completed
Clinical Trials on Short term Pulmonary Rehabilitation
-
King's College LondonHospices Civils de Lyon; University of Bergen; Fondazione IRCCS Istituto Nazionale... and other collaboratorsRecruitingCancerDenmark, United Kingdom, France, Italy, Norway
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingTB - Tuberculosis | TB | TB InfectionIndia
-
Nova Scotia Health AuthorityCompletedSomatic Complaints of Multiple TypesCanada
-
University of MiamiRecruitingSpinal Cord Injuries | Peripheral Nerve InjuriesUnited States
-
Randi UlbergUniversity of OsloCompleted
-
UNEEG Medical A/SCompleted
-
Ben-Gurion University of the NegevSoroka University Medical Center; Soroka Hospital,Beer Sheva,IsraelRecruitingPTSD | Post Traumatic Stress DisorderIsrael
-
Sun Yat-sen UniversityUnknownMultifocal Contact LensesChina
-
Meir Medical CenterUnknownStress, PsychologicalIsrael
-
Mental Health Services in the Capital Region, DenmarkUniversity of Copenhagen; Copenhagen Trial Unit, Center for Clinical Intervention...Completed